About: Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Europe, and Africa. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company engages in the agricultural activities, including seed traits and ag-chemicals activities; and design novel small molecules for drug development by utilizing ChemPass AI, a computational generative AI engine. It also focuses on the development and commercialization of castor bean seeds for industrial uses. In addition, the company medical cannabis products. It has a collaboration with LMU University Hospital Munich to develop novel therapies for hyper-inflammatory diseases driven by dysregulated neutrophil activity, including inflammatory bowel disease (IBD); and with ELEO, Inc. to develop oral small-molecule inhibitors targeting the PCSK9 pathway for the treatment of hyperlipidemia and cardiovascular diseases. The company was incorporated in 1999 and is headquartered in Rehovot, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.33 (-7.32%)
EVGN NASDAQ Evogene
Evogene share price
EVGN price activity
Last Price
$0.330
Change (24hr)
-0.03 USD (7.32%)
Volume
516
Volume (4w avg)
-
Previous Close
$0.36
Last Trade
05 Nov, 2:04 pm GMT+0
Delayed
05 Nov, 2:04 pm GMT+0
EVGN price performance
Delayed
05 Nov, 2:04 pm GMT+0
EVGN details
EVGN Market Signals